Clinical Trial

Phosphatidylinositol Glycan Anchor Biosynthesis Class U Protein in Breast Cancer

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The present study aims to evaluate the serum level of PIGU protein in patients with breast cancer and its relation with clinical, laboratory and pathological data of the patients.
Trial Details
NCT Number NCT07130162
Lead Sponsor Assiut University
Conditions Breast Cancer
Enrollment 96 participants
Start Date 2025-09-01
Primary Completion 2026-09 (estimated)
Study Completion 2026-10 (estimated)
Updated on ClinicalTrials.gov 2025-08-19